Interpretation of single target positivity among SARS-CoV-2 RT-PCR result tests
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently emerged and is responsible for coronavirus disease 19 (COVID-19). Diagnostic tests have been developed, mainly based on reverse-transcriptase PCR (RT-PCR). Most RT-PCR assays target at least two SARS-CoV-2 genes. In so...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-06-01
|
Series: | Journal of Clinical Virology Plus |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667038021000132 |
id |
doaj-7c302d617686489d8c6219f1df65b139 |
---|---|
record_format |
Article |
spelling |
doaj-7c302d617686489d8c6219f1df65b1392021-07-08T04:05:34ZengElsevierJournal of Clinical Virology Plus2667-03802021-06-0111100021Interpretation of single target positivity among SARS-CoV-2 RT-PCR result testsHonorine Fenaux0Théo Ghelfenstein-Ferreira1Maud Salmona2Nadia Mahjoub3Linda Feghoul4Sarah Maylin5Marie-Laure Chaix6Marine Minier7Audrey Gabassi8Jérôme Le Goff9Constance Delaugerre10Laboratoire de virologie, Hôpital Saint Louis –APHP, Paris, France; Corresponding author.Laboratoire de virologie, Hôpital Saint Louis –APHP, Paris, FranceLaboratoire de virologie, Hôpital Saint Louis –APHP, Paris, France; Insight U976, team INSIGHT, Université de Paris, Paris, FranceLaboratoire de virologie, Hôpital Saint Louis –APHP, Paris, FranceLaboratoire de virologie, Hôpital Saint Louis –APHP, Paris, France; Insight U976, team INSIGHT, Université de Paris, Paris, FranceLaboratoire de virologie, Hôpital Saint Louis –APHP, Paris, FranceLaboratoire de virologie, Hôpital Saint Louis –APHP, Paris, France; Inserm U944, Université de Paris, Paris, FranceLaboratoire de virologie, Hôpital Saint Louis –APHP, Paris, FranceLaboratoire de virologie, Hôpital Saint Louis –APHP, Paris, France; Inserm U944, Université de Paris, Paris, FranceLaboratoire de virologie, Hôpital Saint Louis –APHP, Paris, France; Insight U976, team INSIGHT, Université de Paris, Paris, FranceLaboratoire de virologie, Hôpital Saint Louis –APHP, Paris, France; Inserm U944, Université de Paris, Paris, France; Corresponding author at: Laboratoire de virologie, Hôpital Saint Louis –APHP, Paris, France.Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently emerged and is responsible for coronavirus disease 19 (COVID-19). Diagnostic tests have been developed, mainly based on reverse-transcriptase PCR (RT-PCR). Most RT-PCR assays target at least two SARS-CoV-2 genes. In some cases, only one target gene is detected; the interpretation of such cases remains unclear. Objectives: Our objective was to analyse one target positive (OPT) RT-PCR results, using two RT-PCR assays: the Xpert® Xpress SARS-CoV-2 (Cepheid diagnosis, “Cepheid”) and the Cobas® 6800 SARS-CoV-2 Test (Roche Molecular Diagnostics, “Roche”). Methods: All SARS-CoV-2 RT-PCR results performed on respiratory samples with the Roche or the Cepheid tests, from 23rd March to 6th August 2020 were collected. A patient with an OPT result was classified as “probable COVID-19” if they met at least one of the three following criteria: (i) history of a two gene-positive SARS-CoV-2 RT-PCR result, (ii) anti-SARS-CoV-2 antibody (IgG) detection or (iii) compatible chest computed tomography scan (CT-scan). Results: A total of 18,630 and 1189 SARS-CoV-2 RT-PCR tests were performed with the Roche and Cepheid tests, respectively. Among the positive SARS-CoV-2 RT-PCR, 293 samples – corresponding to 264 patients – were OPT (11% of the positive samples). Of these patients, 180 (68%) had at least one of the three criteria listed above and were classified as probable COVID-19. Conclusions: Sixty-eight percent of the patients with an OPT result were classified as probable COVID-19 and are probably at a late stage of infection. Serology and imaging can be helpful to confirm diagnosis.http://www.sciencedirect.com/science/article/pii/S2667038021000132SARS-CoV-2COVID-19Molecular biologyOne target positive RT-PCR result |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Honorine Fenaux Théo Ghelfenstein-Ferreira Maud Salmona Nadia Mahjoub Linda Feghoul Sarah Maylin Marie-Laure Chaix Marine Minier Audrey Gabassi Jérôme Le Goff Constance Delaugerre |
spellingShingle |
Honorine Fenaux Théo Ghelfenstein-Ferreira Maud Salmona Nadia Mahjoub Linda Feghoul Sarah Maylin Marie-Laure Chaix Marine Minier Audrey Gabassi Jérôme Le Goff Constance Delaugerre Interpretation of single target positivity among SARS-CoV-2 RT-PCR result tests Journal of Clinical Virology Plus SARS-CoV-2 COVID-19 Molecular biology One target positive RT-PCR result |
author_facet |
Honorine Fenaux Théo Ghelfenstein-Ferreira Maud Salmona Nadia Mahjoub Linda Feghoul Sarah Maylin Marie-Laure Chaix Marine Minier Audrey Gabassi Jérôme Le Goff Constance Delaugerre |
author_sort |
Honorine Fenaux |
title |
Interpretation of single target positivity among SARS-CoV-2 RT-PCR result tests |
title_short |
Interpretation of single target positivity among SARS-CoV-2 RT-PCR result tests |
title_full |
Interpretation of single target positivity among SARS-CoV-2 RT-PCR result tests |
title_fullStr |
Interpretation of single target positivity among SARS-CoV-2 RT-PCR result tests |
title_full_unstemmed |
Interpretation of single target positivity among SARS-CoV-2 RT-PCR result tests |
title_sort |
interpretation of single target positivity among sars-cov-2 rt-pcr result tests |
publisher |
Elsevier |
series |
Journal of Clinical Virology Plus |
issn |
2667-0380 |
publishDate |
2021-06-01 |
description |
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently emerged and is responsible for coronavirus disease 19 (COVID-19). Diagnostic tests have been developed, mainly based on reverse-transcriptase PCR (RT-PCR). Most RT-PCR assays target at least two SARS-CoV-2 genes. In some cases, only one target gene is detected; the interpretation of such cases remains unclear. Objectives: Our objective was to analyse one target positive (OPT) RT-PCR results, using two RT-PCR assays: the Xpert® Xpress SARS-CoV-2 (Cepheid diagnosis, “Cepheid”) and the Cobas® 6800 SARS-CoV-2 Test (Roche Molecular Diagnostics, “Roche”). Methods: All SARS-CoV-2 RT-PCR results performed on respiratory samples with the Roche or the Cepheid tests, from 23rd March to 6th August 2020 were collected. A patient with an OPT result was classified as “probable COVID-19” if they met at least one of the three following criteria: (i) history of a two gene-positive SARS-CoV-2 RT-PCR result, (ii) anti-SARS-CoV-2 antibody (IgG) detection or (iii) compatible chest computed tomography scan (CT-scan). Results: A total of 18,630 and 1189 SARS-CoV-2 RT-PCR tests were performed with the Roche and Cepheid tests, respectively. Among the positive SARS-CoV-2 RT-PCR, 293 samples – corresponding to 264 patients – were OPT (11% of the positive samples). Of these patients, 180 (68%) had at least one of the three criteria listed above and were classified as probable COVID-19. Conclusions: Sixty-eight percent of the patients with an OPT result were classified as probable COVID-19 and are probably at a late stage of infection. Serology and imaging can be helpful to confirm diagnosis. |
topic |
SARS-CoV-2 COVID-19 Molecular biology One target positive RT-PCR result |
url |
http://www.sciencedirect.com/science/article/pii/S2667038021000132 |
work_keys_str_mv |
AT honorinefenaux interpretationofsingletargetpositivityamongsarscov2rtpcrresulttests AT theoghelfensteinferreira interpretationofsingletargetpositivityamongsarscov2rtpcrresulttests AT maudsalmona interpretationofsingletargetpositivityamongsarscov2rtpcrresulttests AT nadiamahjoub interpretationofsingletargetpositivityamongsarscov2rtpcrresulttests AT lindafeghoul interpretationofsingletargetpositivityamongsarscov2rtpcrresulttests AT sarahmaylin interpretationofsingletargetpositivityamongsarscov2rtpcrresulttests AT marielaurechaix interpretationofsingletargetpositivityamongsarscov2rtpcrresulttests AT marineminier interpretationofsingletargetpositivityamongsarscov2rtpcrresulttests AT audreygabassi interpretationofsingletargetpositivityamongsarscov2rtpcrresulttests AT jeromelegoff interpretationofsingletargetpositivityamongsarscov2rtpcrresulttests AT constancedelaugerre interpretationofsingletargetpositivityamongsarscov2rtpcrresulttests |
_version_ |
1721314436269998080 |